These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16478530)

  • 1. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Che S; Counts SE; Mufson EJ
    J Neurochem; 2006 Mar; 96(5):1401-8. PubMed ID: 16478530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
    Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
    J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.
    Vana L; Kanaan NM; Ugwu IC; Wuu J; Mufson EJ; Binder LI
    Am J Pathol; 2011 Nov; 179(5):2533-50. PubMed ID: 21945902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
    Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
    Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
    Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
    Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
    Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
    J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.
    Mesulam M; Shaw P; Mash D; Weintraub S
    Ann Neurol; 2004 Jun; 55(6):815-28. PubMed ID: 15174015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; Guillozet-Bongaarts AL; Ward SM; He B; Kanaan NM; Mufson EJ; Binder LI; Counts SE
    Neurobiol Aging; 2016 Jun; 42():80-90. PubMed ID: 27143424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.
    Mufson EJ; Counts SE; Fahnestock M; Ginsberg SD
    Curr Alzheimer Res; 2007 Sep; 4(4):340-50. PubMed ID: 17908035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.
    Arendash GW; Lewis J; Leighty RE; McGowan E; Cracchiolo JR; Hutton M; Garcia MF
    Brain Res; 2004 Jun; 1012(1-2):29-41. PubMed ID: 15158158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.
    Mufson EJ; Ginsberg SD; Ikonomovic MD; DeKosky ST
    J Chem Neuroanat; 2003 Dec; 26(4):233-42. PubMed ID: 14729126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease.
    Counts SE; He B; Che S; Ginsberg SD; Mufson EJ
    J Alzheimers Dis; 2009; 18(4):885-96. PubMed ID: 19749437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.
    Tiernan CT; Mufson EJ; Kanaan NM; Counts SE
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):246-259. PubMed ID: 29378005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of the basal forebrain in Alzheimer's disease.
    Jacobs RW; Duong T; Scheibel AB
    Mol Chem Neuropathol; 1992 Aug; 17(1):1-20. PubMed ID: 1388447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.
    Mufson EJ; Counts SE; Perez SE; Binder L
    Neuropeptides; 2005 Jun; 39(3):233-7. PubMed ID: 15893372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.